secwatch.observer — SEC 8-K summary
======================================

Issuer:     PLUS THERAPEUTICS, INC. (PSTV)
CIK:        0001095981
Form:       8-K
Filed at:   2025-02-18T23:59:59+00:00
Accession:  0001193125-25-028151
Event type: debt
Sentiment:  neutral
Materiality: 0.75
Item codes: 1.01, 2.03, 3.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Plus Therapeutics raises ~$3.7M in secured convertible notes, exchanges warrants, and receives $2M CPRIT advance
--------------------------------------------------------------------------------

- Issued $3.36M in secured convertible notes and warrants to purchase ~3M shares at $1.12; aggregate proceeds ~$3.7M.
- Exchanged $3.19M of existing Series A warrants for new secured convertible exchange notes.
- Notes mature Feb 2026, 10% interest, secured by substantially all assets; mandatory conversion if $10M+ qualified financing by March 31, 2025.
- Received $2.0M advance from CPRIT as part of existing $17.6M grant.
- Registration rights with liquidated damages of 1%/month (12% cap) for filing/effectiveness delays.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1095981/000119312525028151/0001193125-25-028151-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1095981/000119312525028151/d916701d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-25-028151

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer